Category: Approval/Launch Region: North America · United States Company: Orasure Technologies Inc

OraSure Technologies OMNIgene GUT Dx microbiome collection device gets de novo authorization from US FDA

By, Admin 1 min read
Share
OraSure Technologies OMNIgene GUT Dx microbiome collection device gets de novo authorization from US FDA
OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced its OMNIgene

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!